PainNCT00241397
Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety
An observational study of Pain and Depression, run by Wyeth is now a wholly owned subsidiary of Pfizer at 91 sites in Belgium.
Trial summary
The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pain, Depression, Anxiety Disorder
- How many people
- 2,560 participants
- Where
- 91 sitesBelgium
- Study dates
- Nov 2005to not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Outpatient must be at least 18 years of age
- Consulting a General Practitioner for painful physical symptoms
- Written informed consent
Who cannot join
- Patient is unable to understand and comply with procedures of the study
- Patient is unable to complete the patient ratings
- Patient has an acute pain with an obvious cause
Trial locations and contacts
91 sites in 1 country.
91 sites in 1 country
Belgium91 sites
Study site
Aarschot, 3200
Study site
Aiseau-Presles, 6250
Study site
Anderlues, 6150
Study site
Andrimont, 4821
Study site
Angleur, 4031
Study site
Ans, 4430
Study site
Anthée, 5520
Study site
Auvelais, 5060
Study site
Avelgem, 8581
Study site
Beauraing, 5570
Study site
Beernem, 8730
Study site
Bekegem-Ichtegem, 8480
Study site
Belgrade, 5001
Study site
Bertogne, 6687
Study site
Betekom, 3130
Study site
Bierges, 1301
Study site
Binche, 7130
Study site
Bioul, 5537
Study site
Braine-l'Alleud, 1420
Study site
Bruges, 8000
Study site
Bruges, 8200
Study site
Brussels, 1040
Study site
Brussels, 1050
Study site
Brussels, 1080
Study site
Brussels, 1083
Study site
Brussels, 1090
Study site
Brussels, 1130
Study site
Brussels, 1140
Study site
Brussels, 1180
Study site
Brussels, 1200
Study site
Charleroi, 6000
Study site
Ciney, 5590
Study site
Couillet, 6010
Study site
Deurne (Antwerpen), 2100
Study site
Dworp, 1653
Study site
Éghezée, 5310
Study site
Eupen, 4700
Study site
Galmaarden, 1570
Study site
Goutroux, 6030
Study site
Grimminge, 9506
Study site
Hatrival, 6870
Study site
Hemiksem, 2620
Study site
Herenthout, 2270
Study site
Hoboken, 2660
Study site
Houdeng-Aimeries, 7110
Study site
Houdeng-Goegnies, 7110
Study site
Incourt, 1315
Study site
Itegem, 2222
Study site
Jabbeke, 8490
Study site
Jambes, 5100
Study site
Jodoigne, 1370
Study site
Kapellen, 2950
Study site
Kettenis, 4701
Study site
Klemskerke, 8420
Study site
Kuurne, 8520
Study site
Laarne, 9270
Study site
Lasne, 1380
Study site
Leuven, 3000
Study site
Lobbes, 6540
Study site
Luttre, 6238
Study site
Mélin, 1370
Study site
Merksem, 2170
Study site
Monceau-sur-Sambre, 6031
Study site
Morlanwelz-Mariemont, 7140
Study site
Moustier S/S, 5190
Study site
Noorderwijk, 2200
Study site
Oudenaarde, 9700
Study site
Ranst, 2520
Study site
Rèves, 6312
Study site
Rixensart, 1330
Study site
Romsée, 4624
Study site
Rotselaar, 3110
Study site
Ruddervoorde, 8020
Study site
Sainte-Marie-sur-Semois, 6740
Study site
Schildewindeke, 9860
Study site
Schoten, 2900
Study site
St-Joris Winge, 3390
Study site
Steenokkerzeel, 1820
Study site
Waarschoot, 9950
Study site
Waha, 6900
Study site
Walem, 2800
Study site
Wavre, 1300
Study site
Wetteren, 9230
Study site
Wevelgem, 8560
Study site
Wilrijk, 2610
Study site
Wommelgem, 2160
Study site
Wondelgem, 9032
Study site
Wuustwezel-Gooreind, 2990
Study site
Zelzate, 9060
Study site
Zemst, 1980
Study site
Zétrud-Lumay, 1370
About this study
Official title: An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.
The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors.
- Conditions
- Pain, Depression, Anxiety Disorder
- Keywords
- pain, depression, anxiety disorder
- Medical subject headings
- Pain, Depression, Anxiety Disorders
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Oct 2005 (estimated)
- Study startNov 2005
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Defined population
- Time perspective
- Other
- Enrolment
- 2,560 participants
Sponsor and investigators
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Medical Monitor, MD, Study director, Wyeth is now a wholly owned subsidiary of PfizerTrial Manager, Principal investigator, For Belgium, trials-BEL@wyeth.com
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00241397
- Sponsor's protocol ID
- 0600B1-102003
- Status last verified
- Mar 2007
- First submitted
- 17 Oct 2005
- Last updated
- 15 Mar 2007
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Mar 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.
- ClinicalTrials.gov ID
- NCT00241397
- Acronym / sponsor ID
- 0600B1-102003
- Conditions
- Pain, Depression, Anxiety Disorder
- Keywords
- pain, depression, anxiety disorder
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,560 participants
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of PfizerIndustry (pharma, biotech, devices)
- Study start
- Nov 2005
- First posted
- 18 Oct 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to assess the prevalence of Major Depression and/or Anxiety Disorder in patients consulting the General Practitioner with acute or chronic painful physical symptoms and to identify risk factors.
Study design
- Observational model
- Defined population
- Time perspective
- Other
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Outpatient must be at least 18 years of age
- Consulting a General Practitioner for painful physical symptoms
- Written informed consent
Key exclusion criteria (3 listed)
- Patient is unable to understand and comply with procedures of the study
- Patient is unable to complete the patient ratings
- Patient has an acute pain with an obvious cause
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Mar 2007.
Related trials for Pain
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Empowered Relief® for Cancer Survivors With Chronic Pain
Chronic Pain Due to Cancer, Pain Catastrophizing
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Effects of Hip Hinge Exercises on Pain, Range of Motion and Functional Disability in Non-specific Low Back Pain.
Low Back Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Medical Monitor, MD study director
Wyeth is now a wholly owned subsidiary of Pfizer
Trial Manager principal investigator
For Belgium, trials-BEL@wyeth.com
91 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pain and Depression, run by Wyeth is now a wholly owned subsidiary of Pfizer at 91 sites in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Mar 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 91 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2007.